Profil
Dakota Gallivan ist Chief Healthcare Compliance Officer & VP bei Reata Pharmaceuticals, Inc. Herr Gallivan hatte zuvor die Position des Compliance Counsel bei Pharmacyclics LLC inne. Herr Gallivan erhielt einen Bachelor-Abschluss vom St. Francis College und einen Master-Abschluss von der Seton Hall University School of Law.
Ehemalige bekannte Positionen von Dakota Gallivan
| Unternehmen | Position | Ende |
|---|---|---|
| REATA PHARMACEUTICALS, INC. | Compliance Officer | 26.09.2023 |
| DERMIRA, INC. | General Counsel | 01.01.2020 |
| PHARMACYCLICS, INC. | General Counsel | 01.04.2018 |
| Medivation, Inc. /Old/ | General Counsel | 01.04.2017 |
| PFIZER, INC. | General Counsel | 01.04.2017 |
Ausbildung von Dakota Gallivan
| St. Francis College | Undergraduate Degree |
| Seton Hall University School of Law | Graduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 1 |
|---|---|
| PFIZER, INC. | Health Technology |
| Private Unternehmen | 4 |
|---|---|
Pharmacyclics LLC
 Pharmacyclics LLC Pharmaceuticals: MajorHealth Technology Pharmacyclics LLC engages in developing and commercializing innovative small-molecule drugs for the treatment of cancer and immune mediated diseases. It has product candidates in clinical development and several preclinical molecules in optimization. The company was founded by Jonathan Sessler and Richard Miller in 1991 and is headquartered in Sunnyvale, CA. | Health Technology |
Reata Pharmaceuticals, Inc.
 Reata Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Reata Pharmaceuticals, Inc. is a clinical stage biopharmaceutical company, which engages in identifying, developing, and commercializing pharmaceutical products. Its product candidates are bardoxolone methyl and omaveloxolone, which activate the transcription factor Nrf2 to restore mitochondrial function, reduce oxidative stress, and resolve inflammation. The company was founded by J. Warren Huff in 2002 and is headquartered in Plano, TX. | Health Technology |
| Medivation, Inc. /Old/ | Health Technology |
Dermira, Inc.
 Dermira, Inc. Pharmaceuticals: MajorHealth Technology Dermira, Inc. is a biopharmaceutical company. It engages in the provision of therapies for chronic skin conditions. The company was founded by Thomas G. Wiggans, Eugene Andrew Bauer, Luis C. Peña, and Christopher M. Griffith on August 18, 2010 and is headquartered in Indianapolis, IN. | Health Technology |
